Dr. Andy Obenaus, a Professor at Loma Linda University and Adjunct Professor in Cell Biology and Neuroscience at UCR, and Dr. Bir Bhanu, a Professor in UCRs School of Engineering, are both part of a team of investigators recently funded by NIH to conduct research on neuroimaging techniques that may ultimately be used to treat...
Sabrina Lin, a graduate student in Dr. Prue Talbot’s lab and Tiffany Satoorian, a PhD student working with Dr. Michael Pirrung, were recipients this year of awards for best presentations at the 10th Annual Cell, Molecular, and Development Biology Research Symposium. Both students gave presentations dealing with their work on human embryonic stem cells (hESC)...
Connie Martin, an undergraduate student in Dr. Talbot’s lab, has received a two year award to study the effects of cigarette smoke on post-implantation embryonic development. Connie will be setting up and using the Embryonic Stem Cell test, to study the effects of cigarette smoke on prenatal development. The Embryonic Stem Cell Test is the...
In January, construction began on UCR’s new Stem Cell Core Facility. This facility is made available through a grant funded by the California Institute for Regenerative Medicine. The Core will be a 2000 square foot laboratory dedicated to research involving stem cells. The facility will feature culture rooms for growing cells and state-of-the-art analytical equipment...
We are very pleased to announce that Dr. Duncan Liew has joined the UCR Stem Cell Center as the Academic Coordinator for the Stem Cell Core. Dr. Liew has extensive experience with human embryonic stem cell biology. After graduating with 1st class honors from the University of Putra Malaysia, he received his Ph.D training at...
Dr Jiayu Liao an Assistant Professor in the Department of Bioengineering published a paper this week in the "Proceeding of the National Academy of Sciences" dealing with human embryonic stem cell pluripotency. Dr. Liao has demonstrated that mTOR is necessary for maintenance of pluripotency in stem cells. His team inhibited mTOR using Rapamycin, a FDA...
The College of Natural and Agricultural Sciences and the Stem Cell Center are very pleased to welcome Dr. Nicole zur Nieden to our campus. Dr. zur Nieden, a stem cell biologist, is joining the UCR faculty this fall and will be a participant in our growing stem cell research base. Dr. zur Nieden received her...
The UCR Stem Cell Center is very pleased to welcome Dr. Andre Obenaus and Yanhong Shi as Adjunct Faculty members. Dr. Obenaus, who will hold an Adjunct Associate Professorship in the Department of Cell Biology and Neuroscience, is on the faculty at Loma Linda University where he is Director of the Non-Invasive Imaging Laboratory in...
Dr. Noboru Sato, an Assistant Professor in the Department of Biochemistry, developed a novel method to grow human embryonic stem cells which is not only cleaner and easier to use than conventional methods of culturing hESCs but also results in hESCs whose pluripotency – the potential to differentiate into any of the specialized cells of...
Dr. Prue Talbot, Professor of Cell Biology and Director of UCRs Stem Cell Center, has recently received a new grant from the Tobacco-Related Disease Research Program (TRDRP) to continue her work with human embryonic stem cells (hESC). Sabrina Lin and Nikki Weng, who are graduate students in the Cell, Molecular and Developmental Biology Graduate Program...
Dr. Nicole zur Nieden, Assistant Professor in the Department of Cell Biology & Neuroscience and member of UCR's Stem Cell Center, recently led a workshop on the 'Practical Considerations on Stem Cell Based Predictive Assays' in London, UK on February 18th. The workshop, which was organized by SMi and held in conjunction with the 'Stem...
The order would not fund the creation of new stem cell lines, but would allow federally funded scientists to conduct research on existing embryonic stem cells that under the Bush administration were off limits. Obama said the full promise of such research "remains unknown" but that it should be explored because of the potential for...
Typically, tobacco companies market harm-reduction cigarettes as being safer than traditional “full-flavored” brands, leading many smokers to conclude that the use of harm-reduction brands lowers their exposure to toxicants. But a UC Riverside study now shows that smoke from these “light” or “low-yield” harm-reduction cigarettes retains toxicity and that this toxicity can affect prenatal development...